Arterial abnormalities in hypertension Morbidity and mortality in hype
rtension are mainly determined by arterial lesions which may occur in
different regional circulations (e.g. kidney, cerebral, coronary circu
lations, causing nephroangiosclerosis, stroke or myocardial infarction
, respectively), Despite arterial heterogeneity, structural and functi
onal abnormalities are usually observed at an early stage of hypertens
ion in both large and small arteries, These alterations modify physiol
ogical and mechanical properties of the arterial wall, which may becom
e clinically evident by increasing arterial pulsatility or pulse press
ure; the alterations facilitate the establishment and progression of a
therosclerosis and arteriosclerosis. Methods of assessing arterial abn
ormalities Several noninvasive techniques can be used to assess haemod
ynamic properties of arteries: (1) casual and ambulatory blood pressur
e measurements can be used to evaluate pulse pressure; (2) pulse press
ure can be measured directly in different sites of the arterial tree u
sing the Tonometer device; (3) ultrasound techniques can be applied, i
ncluding Doppler signals to assess the arterial flow, video-echo signa
ls to analyse the arterial structure such as the intimal-medial thickn
ess and echo-tracking systems far direct measurements of arterial wall
distension and thickness;(4) pulse wave velocity is widely used as an
index of arterial distensibility; this parameter, assessed by the Com
plier device, has shown that hypertensive patients have decreased arte
rial distensibility and that antihypertensive treatment does not alway
s reverse this abnormality. Treatment It is important to evaluate the
effect of cardiovascular risk-reduction measures on the arterial wall,
Large therapeutic trials are necessary to show whether an evaluation
of arterial abnormalities can identify patients with a high cardiovasc
ular risk and contribute to their treatment and prognostic improvement
.